Drawing for HEALTH100 WELLBRIDGE

USPTO serial 99826075

HEALTH100 WELLBRIDGE

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
—
Examiner
RENNEKER, CHRISTOPHER JOHN
Law office
TMO LAW OFFICE 113

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with HEALTH100 WELLBRIDGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebecca Lessard

Rebecca Lessard Verrill Dana, LLPOne Portland Square, 10th FloorPortland, ME 04101-4054United States

Goods and services

ClassDescriptionStatusFirst use
035Retail store and online retail pharmacy services in the field of prescription drugs, healthcare, wellness consumer goods, general consumer merchandise and beauty products; retail mail order services featuring pharmaceuticals and specialty pharmaceuticals; specialty pharmaceuticals distributorship services; procurement, namely, purchasing pharmaceuticals for others; retail store services featuring pharmaceutical products; retail store services featuring generic prescription drugs; retail pharmacy services; business and management consulting in the health care field, namely, providing health care data analytics to health plans and health care providers for the purposes of patient evaluation, care coordination and management, and projected health care utilization; business risk management consultation, namely, identification of gaps in patient care and methods for closing those gaps; facilitating the business administrative coordination of patient care among health plans, pharmaceutical manufacturers, physicians, and long-term care facilities; health care cost containment; cost management for the health care benefit plans of others; consulting services in the cost management of health care; health care utilization and review services; pharmaceutical cost management and drug review utilization services; pharmaceutical utilization services, namely, verification of benefits, prior authorization and review services and coordination of the sale of prescription drugs; providing information and a website about health care utilization, health care cost management, drug utilization, and retail pharmacy services; business administration of medical and pharmaceutical reimbursement collection for patients from private and public sources; business administration of pharmaceutical reimbursement collection programs for others; business administration of employee pharmaceutical benefits; business administration of prepaid employee health care plans; customer relationship management services; management and operation of call centersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 9, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Nov 9, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Sep 14, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 14, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 19, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 19, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 19, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 3, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 3, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 3, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 5, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 4, 2026DOCKASSIGNED TO EXAMINER—
Jun 3, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 15, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
May 15, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance